CTRI/2017/03/008011
Completed
未知
sage of Dapagliflozin - a Sodium Glucose Co-transporter inhibitor, in the management of Type-2 Diabetes Mellitus: A Real world evidence study in Indian patients - FOREFRONT
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Health Condition 1: null- Type 2 Diabetes
- Sponsor
- AstraZeneca Pharma India Ltd
- Status
- Completed
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Patients who provide written informed consent.
- •2\. Patients with previously diagnosed Type\-2 diabetes mellitus
- •3\. Patients with inadequately controlled diabetes (HbA1c \>7%) with existing anti\-diabetic medications, prior to initiation of dapagliflozin treatment.
- •4\. Patients who are taking dapagliflozin within last 3 months.
- •5\.Patients who are having past medical records for demographic information, weight, blood pressure and HbA1c value at the time of dapagliflozin prescribed
Exclusion Criteria
- •1\.Patients with Type\-1 diabetes mellitus
- •2\. Patients with any medical condition which in the opinion of the investigator would interfere with safe completion of the study
- •3\. Pregnant or lactating women
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
The study of dapagliflozin (sodium glucose cotransporter 2 inhibitor) to verify the efficacy of combination therapy in Japanese patients with type 2 diabetesType 2 diabetesJPRN-UMIN000015369Okayama University Hospital nephrology, diabates and endocrinology100
Completed
Phase 4
Effect of Dapagliflozin on Vascular Functions in Patients With Type 2 Diabetes Compared to GliclazideDiabetesNCT02610088Seoul National University Bundang Hospital32
Completed
Not Applicable
Usage of Dapagliflozin in the Management of Type-2 Diabetes Mellitus: A Real World Evidence Study in Indian PatientsType 2 DiabetesNCT03071016AstraZeneca2,000
Completed
Phase 1
Pilot Study to Explore the Efficacy of DAPAglifozin as add-on to Closed-loop Control in Patients With Type 1 DiabetesType1diabetesNCT02987738Kinderkrankenhaus auf der Bult30
Completed
Not Applicable
The potential effect of Dapagliflozin on diabetic macular edemadiabetic macular edema, diabetesJPRN-UMIN000020331Kyoto Prefectural University of Medicine Department of Endocrinology and Metabolism45